Full List Of Stories
Eli Lilly gets EUA for new antibody 'cocktail', which may cut deaths by 70%
Eli Lilly has clinched Emergency Use Approval in the US for an antibody treatment 'cocktail' that may reduce the risk of hospitalisation and death in high-risk patients by as much as 70%.
Sector movers: Homebuilders, Travel names sag
Homebuilders and Travel names dragged on the wider market in the middle of the week, amid profit-taking in the former and after the Transport Secretary defended tougher travel restrictions.
Thursday preview: US jobless claims, AstraZeneca in the spotlight
The economic calendar on Thursday will be exceedingly light with a reading on weekly US unemployment claims the only event that might easily move markets.
Europe close: Stocks slip as investors monitor US stimulus, vaccine news
European shares slipped on Wednesday as investors looked for direction on US stimulus measures and the pace of vaccine rollouts across the continent.
AstraZeneca to invest in new Covid-19 vaccine production in Eastern Germany
AstraZeneca may partner with Germany's IDT Biologika to produce its Covid-19 vaccine in a bid to bolster supplies.
BioNTech starts Covid-19 vaccine production at new Marburg plant
BioNTech has started production of its Covid-19 vaccine from a new manufacturing site in Marburg, Germany.
US CPI falls short of forecasts in January as vehicle prices drag
Inflation at the consumer level in the States undershot economists' forecasts last month amid the drag from falling vehicle prices.